Revenue Generation

Ultrasonometer:
Lease Term:
Monthly Payment:

$15,000*
60 months
$324

*Priced based on typical average rate from competitive manufacturers.
Your Biomedx price on the unit will be substantially lower.

  • It takes less than 5 studies a week to be in profit.
  • At 2 studies per day, the net revenue generation is $17,770 per year.
  • Add your in-house wellness pharmacy sales that result from the testing and that can jump to over $50,000 or more per year in increased clinic revenue.
    •

In-house wellness pharmacy sales….

Let's say you are doing 2 studies per day. Of the studies you do each month, just 30% prove to be candidates for osteoporosis or low bone density management. (Of the post menopausal population on the standard American diet, 30% is conservative.)  This would be 156 women for the year directed to your in-house wellness pharmacy.

Where a pharmaceutical drug like Fosamax alone would cost a woman $60 per month on prescription, for that same money your in-house wellness pharmacy could give her proven natural support with progesterone cream, specific calcium supplementation keyed to her pH biological individuality, mineral and trace mineral support and important vitamins.

156 clients supporting their health at $60 per month gives a gross annual cash flow of $112,320 in supplement sales.  At 40% margin your net is $44,928.

NOTE: This represents on-going residual income from on-going pharmacy sales. As you continue to work with your ultrasonometer, the on-going sales increase your residual cash flow. If you are using a fulfillment house as opposed to an in-house pharmacy, you may take a cut in margin, but you will not be carrying stock or servicing orders.

  • With these potential revenues, you may decide to test every woman that enters your clinic at a very low cost and provide the test as a value added service.

The numbers reflected above may be optimistic for some clinics, conservative for others. Whichever the case, the fact is an ulltrasonometer will identify women with fracture risk, and that issue needs to be addressed.

If you do not provide this service with natural support options in your market, someone else will, or the women in your market will be left with the other less desirable alternatives - medical pharmaceutical intervention.

Using the ultrasonometer brings up another revenue generation analysis that is hard to quantify, i.e. new business generation that specifically results from your entry into the market with your bone densitometer. Taking your unit to church groups, libraries, health shows and other community activities increases exposure and positive public relations.  Also, osteoporosis campaigns are starting to creep into public service announcements in many media markets and you can capitalize on this growing trend.

You can offer the unit to RNs or entrepreneurial type individuals to use in the evenings and on weekends. They can pocket extra money for providing the test to individuals while potential new customers can be directed to your clinic for follow-up service and nutritional guidance.

Note: Leases are structured with various options in terms and monthly payment is dependent on each situation and credit rating.

Reimbursement by Medicare is covered under CPT code 76977. HCFA/Medicare 1999 reimbursement was 1.22 RVU or approximately $42 per study. In 2001 the national average reimbursement for bone ultrasonometry was $58 per study.

Copyright 1998-2005 • All Rights Reserved